Literature DB >> 7723958

Dementia in Parkinson's disease: a population-based study in ambulatory and institutionalized individuals.

F Tison1, J F Dartigues, S Auriacombe, L Letenneur, F Boller, A Alpérovitch.   

Abstract

We examined the frequency of dementia and depressive symptomatology in 60 Parkinson's disease (PD) patients, identified in a large representative sample of the population, aged 65 years and older, living at home or in institutions in Gironde, France. Dementia, diagnosed according to DSM-III-R criteria, was present in 17.6%, and depressive symptomatology, assessed by the Center for Epidemiologic Studies-Depression Scale, was present in 32.7%. The frequency of dementia in PD increased strongly with age and was higher in institutionalized PD patients than in those living at home. PD was significantly associated with dementia for individuals living at home (odds ratio = 8.2, adjusted for age and symptoms of depression.

Entities:  

Mesh:

Year:  1995        PMID: 7723958     DOI: 10.1212/wnl.45.4.705

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  15 in total

Review 1.  Neuropsychiatric aspects of Parkinson's disease.

Authors:  D Aarsland; K Karlsen
Journal:  Curr Psychiatry Rep       Date:  1999-10       Impact factor: 5.285

2.  Donepezil for cognitive impairment in Parkinson's disease: a randomized controlled trial.

Authors:  Karen Marder
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

3.  Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study.

Authors:  R N Alcalay; E Caccappolo; H Mejia-Santana; M -X Tang; L Rosado; M Orbe Reilly; D Ruiz; B Ross; M Verbitsky; S Kisselev; E Louis; C Comella; A Colcher; D Jennings; M Nance; S Bressman; W K Scott; C Tanner; S Mickel; H Andrews; C Waters; S Fahn; L Cote; S Frucht; B Ford; M Rezak; K Novak; J H Friedman; R Pfeiffer; L Marsh; B Hiner; A Siderowf; H Payami; E Molho; S Factor; R Ottman; L N Clark; K Marder
Journal:  Neurology       Date:  2012-03-21       Impact factor: 9.910

4.  Neuropsychological prediction of dementia in Parkinson's disease.

Authors:  F Mahieux; G Fénelon; A Flahault; M J Manifacier; D Michelet; F Boller
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-02       Impact factor: 10.154

Review 5.  Role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinson's disease.

Authors:  J Kulisevsky
Journal:  Drugs Aging       Date:  2000-05       Impact factor: 3.923

6.  Genetic testing and Parkinson disease: assessment of patient knowledge, attitudes, and interest.

Authors:  Dana Clay Falcone; Elisabeth McCarty Wood; Sharon X Xie; Andrew Siderowf; Vivianna M Van Deerlin
Journal:  J Genet Couns       Date:  2011-04-08       Impact factor: 2.537

7.  Imaging changes associated with cognitive abnormalities in Parkinson's disease.

Authors:  Yuko Koshimori; Barbara Segura; Leigh Christopher; Nancy Lobaugh; Sarah Duff-Canning; Romina Mizrahi; Clement Hamani; Anthony E Lang; Kelly Aminian; Sylvain Houle; Antonio P Strafella
Journal:  Brain Struct Funct       Date:  2014-05-13       Impact factor: 3.270

8.  Chocolate consumption is increased in Parkinson's disease. Results from a self-questionnaire study.

Authors:  Martin Wolz; Alice Kaminsky; Matthias Löhle; Rainer Koch; Alexander Storch; Heinz Reichmann
Journal:  J Neurol       Date:  2009-03-13       Impact factor: 4.849

Review 9.  Differential diagnosis of the major progressive dementias and depression in middle and late adulthood: a summary of the literature of the early 1990s.

Authors:  L D Rosenstein
Journal:  Neuropsychol Rev       Date:  1998-09       Impact factor: 7.444

10.  Parkinson's disease dementia: a diminished role for the Lewy body.

Authors:  Leslie S Libow; Pasquale G Frisina; Vahram Haroutunian; Daniel P Perl; Dushyant P Purohit
Journal:  Parkinsonism Relat Disord       Date:  2009-04-05       Impact factor: 4.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.